103 related articles for article (PubMed ID: 38820773)
1. Deep pan-cancer analysis and multi-omics evidence reveal that ALG3 inhibits CD8
Wu Z; Su R; Dai Y; Wu X; Wu H; Wang X; Wang Z; Bao J; Chen J; Xia E
Comput Biol Med; 2024 Jul; 177():108666. PubMed ID: 38820773
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of ALG3 in pan-cancer and validation of ALG3 as an onco-immunological biomarker in breast cancer.
Xue X; Feng Q; Hong X; Lin Z; Luo Y; Li Y; Yao G; Wang N; Chen L
Aging (Albany NY); 2024 Feb; 16(3):2320-2339. PubMed ID: 38329424
[TBL] [Abstract][Full Text] [Related]
3. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
Li J; Wang S; Wang N; Zheng Y; Yang B; Wang X; Zhang J; Pan B; Wang Z
Cell Commun Signal; 2021 Aug; 19(1):89. PubMed ID: 34461944
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein receptor promotes crosstalk between cell stemness and tumor immune microenvironment in breast cancer: a large data-based multi-omics study.
Yuan Q; Lu X; Guo H; Sun J; Yang M; Liu Q; Tong M
J Transl Med; 2023 Nov; 21(1):871. PubMed ID: 38037058
[TBL] [Abstract][Full Text] [Related]
5. A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.
Zhou X; Du J; Liu C; Zeng H; Chen Y; Liu L; Wu D
Front Immunol; 2021; 12():688215. PubMed ID: 34305920
[TBL] [Abstract][Full Text] [Related]
6. Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma.
Yuan Y; Xie B; Guo D; Liu C; Jiang G; Lai G; Zhang Y; Hu X; Wu Z; Zheng R; Huang L
Heliyon; 2023 Jul; 9(7):e18065. PubMed ID: 37539167
[TBL] [Abstract][Full Text] [Related]
7. ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.
Sun X; He Z; Guo L; Wang C; Lin C; Ye L; Wang X; Li Y; Yang M; Liu S; Hua X; Wen W; Lin C; Long Z; Zhang W; Li H; Jian Y; Zhu Z; Wu X; Lin H
J Exp Clin Cancer Res; 2021 Apr; 40(1):149. PubMed ID: 33931075
[TBL] [Abstract][Full Text] [Related]
8. Cancer-cell-secreted CXCL11 promoted CD8
Gao Q; Wang S; Chen X; Cheng S; Zhang Z; Li F; Huang L; Yang Y; Zhou B; Yue D; Wang D; Cao L; Maimela NR; Zhang B; Yu J; Wang L; Zhang Y
J Immunother Cancer; 2019 Feb; 7(1):42. PubMed ID: 30744691
[TBL] [Abstract][Full Text] [Related]
9. Multi-Omics Pan-Cancer Analysis of Procollagen N-Propeptidase Gene Family of ADAMTS as Novel Biomarkers to Associate with Prognosis, Tumor Immune Microenvironment, Signaling Pathways, and Drug Sensitivities.
Chen Y; Xiao C; Fan Q; Zhang Y; Huang Q; Ou Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):151. PubMed ID: 38682182
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X
Front Immunol; 2023; 14():1071675. PubMed ID: 36761737
[TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker.
Feng Z; Chen Y; Cai C; Tan J; Liu P; Chen Y; Shen H; Zeng S; Han Y
Front Immunol; 2022; 13():916594. PubMed ID: 35844598
[TBL] [Abstract][Full Text] [Related]
12. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
[TBL] [Abstract][Full Text] [Related]
13. Exercise Training Improves Tumor Control by Increasing CD8
Gomes-Santos IL; Amoozgar Z; Kumar AS; Ho WW; Roh K; Talele NP; Curtis H; Kawaguchi K; Jain RK; Fukumura D
Cancer Immunol Res; 2021 Jul; 9(7):765-778. PubMed ID: 33839688
[TBL] [Abstract][Full Text] [Related]
14. Expression of ALG3 in Hepatocellular Carcinoma and Its Clinical Implication.
Zhao Z; Zheng Z; Huang J; Wang J; Peng T; Lin Y; Jian Z
Front Mol Biosci; 2022; 9():816102. PubMed ID: 35782861
[No Abstract] [Full Text] [Related]
15. Integrated single-cell and bulk sequencing analyses with experimental validation identify the prognostic and immunological implications of CD226 in pan-cancer.
Ma P; Sun W
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14597-14617. PubMed ID: 37580402
[TBL] [Abstract][Full Text] [Related]
16. The prognostic marker KRT81 is involved in suppressing CD8 + T cells and predicts immunotherapy response for triple-negative breast cancer.
Yan Z; Zhong Z; Shi C; Feng M; Feng X; Liu T
Cancer Biol Ther; 2024 Dec; 25(1):2355705. PubMed ID: 38778753
[TBL] [Abstract][Full Text] [Related]
17. Integration of multiomics analyses reveals unique insights into CD24-mediated immunosuppressive tumor microenvironment of breast cancer.
Hu H; Zhu H; Zhan W; Hao B; Yan T; Zhang J; Wang S; Xu X; Zhang T
Inflamm Res; 2024 Jun; 73(6):1047-1068. PubMed ID: 38622285
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
[TBL] [Abstract][Full Text] [Related]
19. Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of Cancer.
Muliaditan T; Opzoomer JW; Caron J; Okesola M; Kosti P; Lall S; Van Hemelrijck M; Dazzi F; Tutt A; Grigoriadis A; Gillett CE; Madden SF; Burchell JM; Kordasti S; Diebold SS; Spicer JF; Arnold JN
Clin Cancer Res; 2018 Apr; 24(7):1617-1628. PubMed ID: 29339440
[No Abstract] [Full Text] [Related]
20. The pan-cancer multi-omics landscape of key genes of sialylation combined with RNA-sequencing validation.
Wu Z; Wang Z; Wu H; Zheng N; Huang D; Huang Z; Han H; Bao J; Xu H; Zhang R; Du Z; Wu D
Comput Biol Med; 2023 Nov; 166():107556. PubMed ID: 37801920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
